IFP Advisors, Inc - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 165 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2017. The put-call ratio across all filers is 1.57 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$2,602
-69.6%
73
-50.0%
0.00%
Q2 2023$8,546
+65.0%
146
+100.0%
0.00%
Q1 2023$5,179
+32268.8%
73
-68.0%
0.00%
Q4 2022$16
-99.8%
228
+60.6%
0.00%
Q3 2022$10,0000.0%1420.0%0.00%
Q2 2022$10,0000.0%1420.0%0.00%
Q1 2022$10,000142
+3450.0%
0.00%
Q2 2021$0
-100.0%
4
-71.4%
0.00%
Q1 2021$2,000
-50.0%
14
-56.2%
0.00%
Q4 2020$4,000
+300.0%
32
+220.0%
0.00%
Q3 2020$1,000100.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$000.00%
Q3 2019$0
-100.0%
0
-100.0%
0.00%
Q3 2018$1,0000.0%140.0%0.00%
Q2 2018$1,00014
+250.0%
0.00%
Q3 2017$040.0%0.00%
Q2 2017$040.0%0.00%
Q1 2017$040.0%0.00%
Q4 2016$040.0%0.00%
Q3 2016$040.0%0.00%
Q2 2016$0
-100.0%
4
-63.6%
0.00%
Q4 2015$1,000110.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q4 2017
NameSharesValueWeighting ↓
Abingworth LLP 38,100$2,928,0001.67%
Opaleye Management Inc. 80,000$6,149,0001.59%
HIGHLINE CAPITAL MANAGEMENT, L.P. 410,000$31,517,0001.06%
Opus Point Partners Management, LLC 6,311$485,0001.05%
SECTOR GAMMA AS 68,015$5,228,0000.87%
Capital Impact Advisors, LLC 27,074$2,061,0000.76%
FORTALEZA ASSET MANAGEMENT INC/ 1,130$87,0000.71%
CAPITAL INTERNATIONAL LTD /CA/ 46,957$3,610,0000.63%
Virtus ETF Advisers LLC 8,794$676,0000.60%
Rock Springs Capital Management LP 200,000$15,374,0000.59%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders